Semi-individualised Chinese medicine treatment as an adjuvant management for diabetic nephropathy: a pilot add-on, randomised, controlled, multicentre, open-label pragmatic clinical trial

INTRODUCTION: Diabetes mellitus and diabetic nephropathy (DN) are prevalent and costly to manage. DN is the leading cause of end-stage kidney disease. Conventional therapy blocking the renin–angiotensin system has only achieved limited effect in preserving renal function. Recent observational data s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Chan, Kam Wa, Ip, Tai Pang, Kwong, Alfred Siu Kei, Lui, Sing Leung, Chan, Gary Chi Wang, Cowling, Benjamin John, Yiu, Wai Han, Wong, Dickson Wai Leong, Liu, Yang, Feng, Yibin, Tan, Kathryn Choon Beng, Chan, Loretta Yuk Yee, Leung, Joseph Chi Kam, Lai, Kar Neng, Tang, Sydney Chi Wai
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2016
Assuntos:
Renal Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986085/
https://ncbi.nlm.nih.gov/pubmed/27496229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-010741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados